Loading...
Loading...
Comprehensive Guide
Chronic Inflammatory Response Syndrome (CIRS) affects roughly 25% of the population who carry susceptible HLA genotypes. If you have been exposed to water-damaged buildings, this guide covers the science of mycotoxins, the diagnostic workup, the Shoemaker protocol, binder therapy, glutathione support, environmental testing, and the dietary strategies that accelerate recovery.
25%
Population genetically susceptible
5
Major mycotoxin classes
8
Critical lab markers
11
Shoemaker protocol steps
Understanding the Disease
CIRS is a multi-system, multi-symptom illness caused by biotoxin exposure in genetically susceptible individuals. It is not an allergy. It is an innate immune dysregulation.
In a healthy person, the adaptive immune system recognizes biotoxins (mycotoxins, endotoxins, actinomycetes) and creates antibodies to tag them for removal. In genetically susceptible individuals (those with specific HLA-DR genotypes), the immune system cannot “see” and tag these biotoxins.
The biotoxins circulate indefinitely, continuously triggering the innate immune system. This creates a self-perpetuating cycle of inflammation that does not resolve on its own — even after leaving the exposure source. The toxins are stored in fat tissue and recirculate through enterohepatic recirculation (gut-liver loop).
This is why CIRS patients can remain sick for years after the initial exposure. Without intervention (binders, detox support), the biotoxins are never cleared. They continue to stimulate cytokine production, disrupt neuropeptides, and damage tissues systemically.
Exposure
Water-damaged building releases mycotoxins, endotoxins, beta-glucans, hemolysins, proteinases, and actinomycetes into indoor air
Failed Clearance
HLA-susceptible immune system cannot tag biotoxins with antibodies for removal. Toxins persist and recirculate.
Innate Immune Activation
Toll-like receptors trigger cytokine storm: TGF-beta1, MMP-9, C4a, C3a escalate. Chronic inflammation begins.
Neuropeptide Collapse
MSH, VIP, and ADH are depleted. This disrupts hormone regulation, pain modulation, gut barrier, and pulmonary function.
Multi-System Dysfunction
Brain fog, fatigue, pain, respiratory issues, gut problems, immune collapse, and hormonal chaos. The full CIRS picture.
The HLA-DR gene controls how your immune system presents foreign antigens to T-cells. Specific haplotypes — particularly 11-3-52B, 4-3-53, 12-3-52B, and 14-5-52B — have “blind spots” for biotoxins. If you carry one of these genotypes, your adaptive immune system never mounts a proper antibody response to mycotoxins.
This explains the common scenario: a family of four lives in a water-damaged home. Two members become severely ill (they carry susceptible HLA types), while the other two are completely fine (non-susceptible genotypes). The exposure is identical — the genetics determine who gets sick. HLA-DR testing is a one-time blood test that provides lifelong clarity about your biotoxin susceptibility.
Know Your Enemy
Mycotoxins are secondary metabolites produced by mold. They are invisible, odorless, and can cause damage at concentrations measured in parts per billion. Understanding which mycotoxins you are exposed to guides treatment.
Source Organisms
Aspergillus flavus, A. parasiticus
Common In
Corn, peanuts, tree nuts, grains, spices, and water-damaged buildings
Health Effects
Most potent naturally occurring carcinogen. Causes liver damage, immune suppression, and DNA mutations. Aflatoxin B1 is classified as a Group 1 carcinogen by the WHO. Disrupts protein synthesis and can cause acute aflatoxicosis at high doses.
Testing
Detectable in urine via ELISA and LC-MS/MS. Blood testing measures aflatoxin-albumin adducts for chronic exposure assessment.
Source Organisms
Aspergillus ochraceus, Penicillium verrucosum
Common In
Coffee, wine, grains, dried fruits, and water-damaged buildings — the most common indoor mycotoxin
Health Effects
Nephrotoxic (kidney damage), neurotoxic, and immunosuppressive. Crosses the blood-brain barrier, contributing to brain fog and cognitive impairment. Has an extremely long half-life (35 days), meaning it accumulates with ongoing exposure. Suspected carcinogen (Group 2B).
Testing
Urine testing via RealTime Labs or Mosaic Diagnostics. Most commonly elevated mycotoxin on indoor exposure panels.
Source Organisms
Stachybotrys chartarum (black mold), Fusarium species
Common In
Water-damaged drywall, ceiling tiles, HVAC systems — Stachybotrys requires very wet conditions
Health Effects
Among the most toxic mycotoxins. Inhibit protein synthesis at the ribosomal level. Cause hemorrhagic inflammation, immune suppression, skin irritation, and neurological damage. Used as biological warfare agents (T-2 toxin). Extremely potent even at low concentrations.
Testing
Urine testing. Can be difficult to detect because trichothecenes are rapidly metabolized. Provocation testing with glutathione may improve detection.
Source Organisms
Aspergillus fumigatus
Common In
Water-damaged buildings, soil, compost — A. fumigatus is ubiquitous in the environment
Health Effects
Potent immunosuppressant that destroys immune cells (induces apoptosis in macrophages, neutrophils, and T-cells). Disrupts the NF-kB pathway. Creates a state of functional immune deficiency, making patients susceptible to secondary infections. Damages the gut barrier.
Testing
Available through Mosaic Diagnostics (formerly Great Plains) mycotoxin panel. Often elevated alongside other mycotoxins in multi-mold environments.
Source Organisms
Fusarium graminearum, F. culmorum
Common In
Corn, wheat, barley, and other cereal grains — primarily a dietary exposure but also found in water-damaged buildings
Health Effects
Estrogenic mycotoxin — mimics estrogen and binds to estrogen receptors. Causes hormonal disruption, reproductive issues, and may contribute to estrogen-dominant conditions. Can cause precocious puberty in children. Hepatotoxic at high doses.
Testing
Detectable in urine via mycotoxin panels. Levels may correlate with estrogen dominance symptoms.
Important: Mycotoxins are not the only biotoxins in water-damaged buildings. Endotoxins (from gram-negative bacteria), beta-glucans (from mold cell walls), hemolysins, actinomycetes, and volatile organic compounds (VOCs) all contribute to the inflammatory load. This is why mold illness is more accurately described as “water-damaged building illness” or biotoxin illness — the problem is broader than mycotoxins alone.
Recognize the Pattern
CIRS affects virtually every organ system because the inflammatory cascade is systemic. The hallmark is the sheer number and diversity of symptoms — patients often report 15-25 symptoms across 8+ body systems simultaneously.
Brain fog, difficulty concentrating, word-finding problems, disorientation, memory loss, headaches, light sensitivity, numbness/tingling, vertigo, tremors
Joint pain (migratory, without swelling), muscle aches, morning stiffness, cramping, weakness, ice-pick pains
Chronic sinus congestion, shortness of breath, air hunger, cough, wheezing, recurrent sinus infections
Abdominal pain, bloating, diarrhea, nausea, appetite changes, food sensitivities, leaky gut
Debilitating fatigue not relieved by rest, post-exertional malaise, non-restorative sleep, night sweats, temperature dysregulation
Anxiety, depression, mood swings, irritability, depersonalization, cognitive decline that mimics early dementia
Frequent illness, slow wound healing, new food sensitivities, chemical sensitivities, histamine intolerance, autoimmune flares
Low MSH (sun sensitivity, sleep disruption), low ADH (frequent urination, thirst), low VIP (shortness of breath), cortisol dysregulation, thyroid dysfunction
If three or more of the following are true, CIRS should be on your differential diagnosis:
First-Line Screening
The VCS test is a rapid, inexpensive screening tool that detects neurotoxin-mediated damage to the visual system. It is 92% sensitive for biotoxin illness and takes less than 15 minutes.
The VCS test measures your ability to distinguish between lines of varying contrast against a gray background. Biotoxins disrupt neural signal transmission in the visual cortex and retinal nerve fiber layer, reducing contrast sensitivity in specific spatial frequency ranges.
A positive VCS test (failing one or both eyes at specific frequencies) indicates that neurotoxins are present and affecting your nervous system. It does not diagnose CIRS specifically — other neurotoxins (Lyme disease, heavy metals) can cause a positive result — but it is an excellent initial screening tool.
The test is available online at VCSTest.com (a validated digital version) or in-office through CIRS-literate practitioners. The online version costs approximately $15 and provides immediate results. Repeat testing during treatment tracks neurological recovery objectively.
Urine mycotoxin panels directly measure mycotoxin metabolites excreted by the kidneys. The two primary laboratories are:
Pro tip: Take 500-1,000 mg liposomal glutathione daily for 7 days before collecting your urine sample. This “provocation” mobilizes mycotoxins stored in fat tissue, increasing test sensitivity and reducing false negatives.
The Full Picture
These 8 markers form the diagnostic and treatment-monitoring panel for CIRS. Most conventional doctors do not order them. You will need a CIRS-literate practitioner or functional medicine doctor.
Transforming Growth Factor Beta-1
Key fibrotic and inflammatory cytokine. Chronically elevated in CIRS. Drives tissue remodeling, fibrosis, and autoimmune activation. Contributes to neurological symptoms and restrictive lung disease.
Standard Range
< 2,380 pg/mL
Optimal
< 2,380 pg/mL
CIRS Relevance
Elevated in ~50% of CIRS patients. Among the last markers to normalize during treatment. Associated with autoimmune activation when persistently high.
Matrix Metalloproteinase-9
Enzyme that breaks down extracellular matrix. Elevated MMP-9 increases blood-brain barrier permeability, allowing inflammatory cytokines to enter the brain and cause neurological symptoms.
Standard Range
85-332 ng/mL
Optimal
< 332 ng/mL
CIRS Relevance
Correlates strongly with brain fog and cognitive symptoms. Responds relatively quickly to binder therapy. Often the first marker to improve.
Melanocyte-Stimulating Hormone (alpha-MSH)
Master regulatory hormone that controls cytokine production, pituitary hormones, endorphin production, and gut barrier integrity. Low MSH is a hallmark of CIRS.
Standard Range
35-81 pg/mL
Optimal
35-81 pg/mL
CIRS Relevance
Low in ~95% of CIRS patients. Causes sun sensitivity, chronic pain (low endorphins), leaky gut, sleep disruption, and inability to control inflammatory cytokines. Difficult to restore without VIP therapy.
Vasoactive Intestinal Peptide
Neuropeptide that regulates pulmonary artery pressure, inflammatory response, gut motility, and circadian rhythm. Low VIP causes shortness of breath, cognitive impairment, and inflammatory dysregulation.
Standard Range
23-63 pg/mL
Optimal
23-63 pg/mL
CIRS Relevance
Low in ~98% of CIRS patients. VIP nasal spray is the final step of the Shoemaker protocol and often produces the most dramatic improvement. Requires all other markers to be corrected first.
Complement Component 4a
Complement activation marker indicating innate immune system activation. Extremely elevated levels signal active biotoxin exposure and ongoing inflammatory response.
Standard Range
0-2,830 ng/mL
Optimal
< 2,830 ng/mL
CIRS Relevance
Can spike to 10,000-20,000+ ng/mL in active CIRS. Drops rapidly when the patient is removed from the contaminated environment. Useful for confirming ongoing vs. past exposure.
Vascular Endothelial Growth Factor
Controls blood vessel formation and capillary permeability. Both high and low values are abnormal in CIRS. Low VEGF restricts oxygen delivery to tissues; high VEGF causes capillary leak.
Standard Range
31-86 pg/mL
Optimal
31-86 pg/mL
CIRS Relevance
Low VEGF contributes to fatigue and muscle pain due to reduced oxygen delivery. Can swing from low to high during treatment. Requires monitoring throughout the protocol.
Antidiuretic Hormone & Serum Osmolality
ADH regulates water retention. In CIRS, ADH is often low relative to osmolality, causing chronic dehydration despite adequate water intake — frequent urination, thirst, and static shocks.
Standard Range
ADH: 1.0-13.3 pg/mL
Optimal
ADH appropriate to osmolality
CIRS Relevance
ADH-osmolality dysregulation affects ~60% of CIRS patients. Explains why patients feel dehydrated despite drinking large amounts of water. Chronic electrolyte imbalance results.
Human Leukocyte Antigen - DR Isotype
Genetic marker — does not change with treatment. Specific HLA-DR haplotypes confer susceptibility to biotoxin illness because the immune system cannot properly recognize and clear biotoxins.
Standard Range
No standard range — genotype test
Optimal
No optimal — genetic marker
CIRS Relevance
~25% of the population carries mold-susceptible HLA genotypes. Multi-susceptible (4-3-53) is the highest risk. 11-3-52B is the dreaded 'multi-susceptible' genotype. This is a one-time test that explains why certain people get sick from mold while others in the same building do not.
Where to test: These markers can be ordered through LabCorp or Quest Diagnostics with the correct test codes. Many CIRS practitioners use online ordering services like DirectLabs or Life Extension for patient self-ordering. HLA-DR requires a specific PCR-based genotyping test — ensure your lab runs the full HLA-DR DRB1, DQ, and DRB3/4/5 panel.
Want This Personalized?
This guide gives you the science. A CryoCove coach gives you the personalization — the right dose, timing, and integration with your other 8 pillars.
The Gold Standard
Developed by Dr. Ritchie Shoemaker over 20+ years and thousands of patients, this sequential protocol addresses each layer of CIRS pathophysiology. Each step must be completed before proceeding to the next.
The most critical step. No treatment works while ongoing exposure continues. Test the environment with ERMI or HERTSMI-2. Remediate or relocate. This single step improves symptoms in many patients within days to weeks.
Begin prescription binder therapy to clear circulating biotoxins. CSM 4 g four times daily for 1-3 months. Monitor VCS test for improvement. If VCS normalizes and symptoms improve, proceed to the next step.
Test for Multiple Antibiotic Resistant Coagulase Negative Staphylococci in deep nasal cultures. If present, treat with BEG spray (Bactroban, EDTA, Gentamicin) or colloidal silver nasal spray for 30 days. MARCoNS produces exotoxins that further suppress MSH.
If antigliadin antibodies are elevated, implement a strict gluten-free diet for 3+ months. Gluten sensitivity is common in CIRS and perpetuates gut inflammation and leaky gut. Retest to confirm normalization.
CIRS often disrupts DHEA-S, testosterone, and estradiol. If androgens are low, address with DHEA supplementation (typically 25-50 mg for men, 5-15 mg for women) under physician guidance. Do not supplement testosterone directly — correct the upstream cause.
If ADH is low relative to osmolality, increase water and electrolyte intake. DDAVP (desmopressin) may be prescribed for severe cases. Proper hydration status is required before advancing to the next steps.
If MMP-9 remains elevated after binders and MARCoNS treatment, implement a strict no-amylose diet (restrict starchy foods). High-dose omega-3 fatty acids (EPA/DHA 3-4 g daily) help reduce MMP-9. Pioglitazone (Actos) may be used in refractory cases.
Low VEGF restricts oxygen delivery. High-dose omega-3s, exercise (as tolerated), and the no-amylose diet typically normalize VEGF. If VEGF remains abnormal, it may indicate ongoing exposure — retest the environment.
If C3a is elevated, it may indicate persistent biotoxin exposure or a secondary inflammatory trigger. Statin therapy (low-dose) is sometimes used. Rule out Lyme disease, which can co-activate complement pathways.
Persistently elevated TGF-beta1 drives autoimmunity and fibrosis. Losartan (an ARB blood pressure medication) is used off-label to lower TGF-beta1. This step requires physician management and serial monitoring.
The final step. Vasoactive Intestinal Peptide nasal spray (50 mcg 4 times daily) restores the regulatory neuropeptide that CIRS depletes. All preceding markers must be in range before starting VIP. Often produces dramatic improvement in fatigue, cognition, and shortness of breath. Requires compounding pharmacy.
Critical note: The Shoemaker protocol is a medical treatment that requires physician supervision. Several steps involve prescription medications (cholestyramine, DDAVP, pioglitazone, losartan, VIP). Do not attempt to self-treat CIRS. Find a practitioner certified through the Shoemaker Protocol certification program or an experienced functional medicine doctor familiar with biotoxin illness. The protocol is sequential for a reason — each step prepares the body for the next. Skipping ahead causes setbacks.
Core Treatment
Binders work by adsorbing mycotoxins in the gastrointestinal tract, preventing enterohepatic recirculation — the process where toxins are excreted in bile, reabsorbed in the intestines, and recycled back to the liver indefinitely.
4 g (one packet), 4 times daily on an empty stomach
The gold standard binder in the Shoemaker protocol. A bile acid sequestrant that binds mycotoxins in the gut, preventing enterohepatic recirculation (the recycling of toxins from gut back to liver). Binds aflatoxins, ochratoxin A, and other polar mycotoxins with high affinity.
Must be taken 30 minutes before or 1 hour after food and 2 hours away from other medications and supplements. Can cause constipation — increase water and magnesium. The pure resin form (not Questran Light, which contains aspartame) is preferred. Takes 1-3 months for full effect.
625 mg tablets, 3 tablets twice daily
Alternative bile acid sequestrant for patients who cannot tolerate cholestyramine. Binds biotoxins similarly but with fewer GI side effects. Less studied than CSM for CIRS specifically but clinically effective.
Better tolerated than CSM. Take 30 minutes before meals. Still requires separation from other medications. Some practitioners start with Welchol and switch to CSM if insufficient response.
500-1,000 mg, 2-3 times daily between meals
Broad-spectrum binder that adsorbs mycotoxins, endotoxins, and other biotoxins in the GI tract through surface-area binding. Coconut-shell-derived charcoal has the highest binding capacity. Non-specific — binds both toxins and nutrients.
Must be taken at least 2 hours away from food, medications, and supplements (it will bind them). Can cause constipation and dark stools. Often used as an initial binder before prescription options or as a complement to CSM. Short-term use preferred due to nutrient binding.
1 tablespoon in water, 1-2 times daily on an empty stomach
Calcium bentonite clay binds aflatoxins with high specificity. Its layered structure creates a large surface area for toxin adsorption. Also binds heavy metals and endotoxins. Has been used for detoxification for centuries across cultures.
Food-grade calcium bentonite only — never sodium bentonite. Take with plenty of water. Can bind minerals, so separate from mineral supplements by 2+ hours. Some products contain lead — choose third-party tested brands. Pairs well with other binders.
3-5 g daily, split into 2-3 doses with meals
Broken-cell-wall chlorella binds mycotoxins, heavy metals, and dioxins. Unique among binders because it also provides chlorophyll, amino acids, B-vitamins, and minerals. Supports Phase II liver detoxification (glucuronidation, glutathione conjugation).
Must be broken-cell-wall form for absorption and binding efficacy. Start low (1 g) and increase gradually — can cause die-off reactions. Some patients with mold illness react to chlorella (it is a biological product). Discontinue if symptoms worsen. Organic, third-party tested.
Detox Powerhouse
Glutathione is the body's master antioxidant and the primary molecule for Phase II detoxification of mycotoxins. CIRS patients are almost universally glutathione-depleted because the ongoing oxidative stress from biotoxins exhausts their supply.
500-1,000 mg daily
Direct glutathione supplementation. Liposomal form survives stomach acid and achieves meaningful intracellular levels. The body's master antioxidant and primary Phase II detoxification conjugate. Critical for mycotoxin clearance. Can be used as a provocation agent before mycotoxin urine testing.
600-1,800 mg daily
Rate-limiting precursor to glutathione synthesis. Replenishes intracellular glutathione stores. Also has direct antioxidant and mucolytic properties. Supports liver detoxification and reduces oxidative stress from mycotoxin exposure.
3-5 g daily
Second amino acid building block of glutathione (along with cysteine and glutamate). Most people are glycine-deficient. Also supports Phase II glucuronidation in the liver, collagen synthesis, and sleep quality. Inexpensive and well-tolerated.
300-600 mg daily (R-lipoic acid preferred)
Recycles glutathione, vitamin C, and vitamin E — keeping them in their active, reduced forms. Both fat- and water-soluble, so it works in all compartments of the cell. Supports mitochondrial function and chelates heavy metals.
200 mcg daily (selenomethionine form)
Essential cofactor for glutathione peroxidase, the enzyme that uses glutathione to neutralize reactive oxygen species. Deficiency impairs the entire glutathione system. Brazil nuts (2-3 daily) are the best food source.
200-400 mg standardized extract daily
Hepatoprotective — protects liver cells from mycotoxin damage. Increases glutathione levels in the liver by up to 35%. Supports Phase I and Phase II liver detoxification pathways. Well-studied for liver support across dozens of clinical trials.
While glutathione is essential for recovery, it must be introduced carefully in CIRS patients. Glutathione mobilizes mycotoxins from fat storage into circulation for excretion. If binder therapy is not in place, these mobilized toxins can be reabsorbed through enterohepatic recirculation, causing a severe Herxheimer reaction — dramatically worsened symptoms.
The correct sequence: Start binders first (1-2 weeks minimum). Once binder therapy is established and tolerated, slowly introduce glutathione support. Begin with NAC (gentler, indirect glutathione precursor) before adding liposomal glutathione directly. Start at 250 mg and increase to 500-1,000 mg over 2-4 weeks. If symptoms worsen, reduce the dose and increase binders. Always take glutathione at least 2 hours away from binders.
Fix the Source
No amount of binders, supplements, or protocols will work if you are still being exposed. Identifying and eliminating the environmental source is the single most important step in CIRS recovery.
Method
Dust sample collected with Swiffer cloth, analyzed via DNA-based MSQPCR technology
What It Measures
Quantifies 36 mold species — 26 water-damage indicator species and 10 common outdoor species. Produces a single ERMI score from -10 to 20+.
Interpretation
ERMI < 2: safe for most people. ERMI 2-5: borderline, may trigger symptoms in genetically susceptible individuals. ERMI > 5: elevated mold levels, remediation recommended. CIRS patients should aim for ERMI < 2.
Cost
~$290-350
Method
Same dust sample as ERMI, but focuses on 5 of the most dangerous species
What It Measures
Targets Aspergillus penicillioides, A. versicolor, Chaetomium globosum, Stachybotrys chartarum, and Wallemia sebi — the species most strongly associated with CIRS.
Interpretation
Score < 11: safe for CIRS patients. Score 11-15: borderline, interpret with clinical context. Score > 15: unsafe for CIRS patients, remediation or relocation required. This is the preferred screening test for CIRS-specific risk.
Cost
~$170-200
Method
Air pump draws a measured volume of air through a collection cassette, analyzed via microscopy
What It Measures
Total spore count per cubic meter of air and genus-level identification. Captures what is currently airborne at the time of sampling.
Interpretation
Provides a snapshot, not a comprehensive assessment. Results vary with HVAC status, humidity, and recent disturbance. Indoor spore counts should be lower than outdoor counts, and the species profile should mirror the outdoor air. Useful for post-remediation verification.
Cost
~$100-300 per sample location
Method
Specialized collection device captures mycotoxin particles on a filter, analyzed via LC-MS/MS
What It Measures
Airborne mycotoxin levels (aflatoxins, ochratoxin A, trichothecenes) rather than spore counts. Detects the actual toxic compounds, not just the organisms that produce them.
Interpretation
Newer and less standardized than ERMI. Any detectable mycotoxin in indoor air is concerning. Particularly useful when mold is hidden (inside walls, HVAC) and spore counts appear normal but patients are symptomatic.
Cost
~$300-500
Sweat It Out
Sweating is a primary excretory pathway for mycotoxins, heavy metals, and other biotoxins. Sauna therapy accelerates the detoxification process when combined with proper binder therapy.
Week 1-2 (Introduction)
10-15 minutes at 120-130 degrees Fahrenheit. Many CIRS patients are heat-sensitive initially. Stop if you feel faint, nauseous, or experience a worsening of symptoms.
Week 3-4 (Building)
20-30 minutes at 130-140 degrees Fahrenheit. Take binders 30 minutes before the session to capture mobilized toxins in the gut.
Week 5+ (Maintenance)
30-45 minutes at 140-150 degrees Fahrenheit, 3-5 times per week. Shower immediately after to remove excreted toxins from the skin. Replenish electrolytes.
Key: Always shower immediately after sauna. Toxins excreted through sweat sit on the skin surface and can be reabsorbed. Use a clean towel. Wash sauna clothing after every session. Hydrate aggressively with electrolytes before, during, and after.
Fuel Recovery
What you eat during CIRS recovery matters profoundly. The right diet reduces inflammatory load, avoids further mycotoxin ingestion, repairs the gut barrier, and supports detoxification pathways.
Wild-caught salmon, sardines, pasture-raised eggs, organic chicken, grass-fed beef, bone broth, dark leafy greens, cruciferous vegetables, berries (low-sugar), avocado, olive oil, coconut oil, fermented vegetables, ginger, turmeric
Corn (high aflatoxin risk), peanuts (high aflatoxin), wheat/gluten, sugar, alcohol, coffee (ochratoxin source), dried fruits (mycotoxin concentration), processed foods, seed oils, dairy (initially), high-starch foods (per Shoemaker low-amylose protocol)
Omega-3 (EPA/DHA 3-4 g), vitamin D3+K2, magnesium glycinate, B-complex (methylated forms), zinc, probiotics (spore-based preferred), digestive enzymes, collagen or bone broth protein
Dr. Shoemaker specifically recommends a low-amylose diet for CIRS patients with elevated MMP-9 and leptin. Amylose is a form of starch found in grains, potatoes, bananas, and root vegetables. In CIRS, elevated leptin (leptin resistance) disrupts the normal appetite-satiety cycle and promotes fat storage — which sequesters more mycotoxins.
The low-amylose diet reduces insulin and leptin levels, helping to break this cycle. Restrict: bread, pasta, rice, potatoes, corn, bananas, and sugary foods. Focus on: proteins, non-starchy vegetables, healthy fats, and low-glycemic fruits (berries). This is not a permanent diet — it is therapeutic for the duration of CIRS treatment and can be liberalized once MMP-9 and leptin normalize.
Gut repair is essential. CIRS causes intestinal permeability (leaky gut) through low MSH and direct mycotoxin damage to the gut lining. Bone broth (glycine, proline, glutamine), L-glutamine supplementation (5-10 g daily), spore-based probiotics, and fermented vegetables support gut barrier restoration. Fix the gut and you reduce the systemic inflammatory load significantly.
What to Expect
CIRS recovery is not linear. Understanding the typical timeline and warning signs of re-exposure helps you stay on track and protect your progress.
Week 1-2
Initial symptom relief after leaving contaminated environment. Brain fog may lift partially. Energy starts to return in spurts.
Month 1-2
Binder therapy reduces circulating biotoxin load. VCS test begins to improve. Joint pain and sinus symptoms often improve first.
Month 3-6
Lab markers (MMP-9, C4a) begin to normalize. Cognitive function improves significantly. Exercise tolerance increases. MARCoNS treatment completed.
Month 6-12
TGF-beta1 and MSH approach normal ranges. Hormonal function recovering. Most daily symptoms resolved. VIP therapy may begin if all markers are in range.
Month 12-18+
Full protocol completion. Lab markers normalized. VIP therapy restoring remaining neuropeptide function. Return to baseline health for most patients.
Even after recovery, genetically susceptible individuals remain vulnerable to future biotoxin exposures. Recognize these early warning signs:
Prevention: Keep a HEPA air purifier running in your bedroom. Test any new home or office with ERMI/HERTSMI-2 before committing. Maintain glutathione support (NAC 600 mg daily) as a long-term protective measure. Keep binders on hand for immediate use if re-exposure is suspected.
FAQ
Inflammation
Understand the inflammatory cascade that CIRS triggers, key biomarkers, and how to resolve chronic inflammation.
Sauna
Deep dive into sauna protocols, heat shock proteins, and detoxification pathways critical for mold recovery.
Gut Health
Repair the gut barrier that CIRS destroys. Leaky gut drives systemic inflammation in mold illness.
Mold illness is one of the most underdiagnosed conditions in medicine. A CryoCove coach can help you navigate the diagnostic process, build your recovery protocol, and coordinate the environmental, medical, and lifestyle interventions needed for full recovery.